share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Hoge Stephen

SEC announcement ·  Jun 19 04:12
Summary by Futu AI
On June 17, 2024, Stephen Hoge, President of Moderna, Inc. [MRNA], completed a sale of 15,000 shares of the company's common stock. The transaction was executed at a price of $138.16 per share, resulting in a total sale value of $2,072,400. Following the sale, Hoge's direct holdings in Moderna amount to 1,457,089 shares. Additionally, Hoge has indirect beneficial ownership of 156,049 shares, which includes 4,116 shares held by Valhalla, LLC and 151,933 shares held by a Trust.
On June 17, 2024, Stephen Hoge, President of Moderna, Inc. [MRNA], completed a sale of 15,000 shares of the company's common stock. The transaction was executed at a price of $138.16 per share, resulting in a total sale value of $2,072,400. Following the sale, Hoge's direct holdings in Moderna amount to 1,457,089 shares. Additionally, Hoge has indirect beneficial ownership of 156,049 shares, which includes 4,116 shares held by Valhalla, LLC and 151,933 shares held by a Trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.